The chemical substance known as "(-)-(2R,4R)-4-[2-Amino-6-(cyclopropylamino)-9H-purin-9-yl]-1,3-dioxolane-2-methanol," with the CAS number 280138-71-8, is a purine derivative characterized by its complex structure, which includes a dioxolane ring and an amino group. This compound exhibits chirality, indicated by the specific stereochemistry at the 2R and 4R positions, which can influence its biological activity and interactions. It is primarily studied for its potential pharmacological properties, particularly in the context of nucleoside analogs, which can play a role in antiviral and anticancer therapies. The presence of the cyclopropylamino group suggests that it may interact with biological targets in a unique manner, potentially enhancing its efficacy or selectivity. Additionally, the compound's solubility, stability, and reactivity are influenced by its functional groups, making it a subject of interest in medicinal chemistry and drug development. Further research is necessary to fully elucidate its mechanisms of action and therapeutic potential.

(-)-(2R,4R)-4-[2-Amino-6-(cyclopropylamino)-9H-purin-9-yl]-1,3-dioxolane-2-methanol

280138-71-8: The chemical substance known as "(-)-(2R,4R)-4-[2-Amino-6-(cyclopropylamino)-9H-purin-9-yl]-1,3-dioxolane-2-methanol," with the CAS number 280138-71-8, is a purine derivative characterized by its complex structure, which includes a dioxolane ring and an amino group. This compound exhibits chirality, indicated by the specific stereochemistry at the 2R and 4R positions, which can influence its biological activity and interactions. It is primarily studied for its potential pharmacological properties, particularly in the context of nucleoside analogs, which can play a role in antiviral and anticancer therapies. The presence of the cyclopropylamino group suggests that it may interact with biological targets in a unique manner, potentially enhancing its efficacy or selectivity. Additionally, the compound's solubility, stability, and reactivity are influenced by its functional groups, making it a subject of interest in medicinal chemistry and drug development. Further research is necessary to fully elucidate its mechanisms of action and therapeutic potential.

<p>SPD-756, a nucleoside reverse transcriptase inhibitor, is used potentially for the treatment of HIV infection.</p>

CAS 280138-71-8

(-)-(2R,4R)-4-[2-Amino-6-(cyclopropylamino)-9H-purin-9-yl]-1,3-dioxolane-2-methanol

SPD-756

Ref: TM-T28833

[(2R,4R)-4-[2-Amino-6-(cyclopropylamino)purin-9-yl]-1,3-dioxolan-2-yl]methanol

Ref: TR-A541280